Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinica (Q71545358)
Jump to navigation
Jump to search
scientific article published on 01 October 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinica |
scientific article published on 01 October 1996 |
Statements
Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinical Research on AIDS (English)
Saravolatz LD
Winslow DL
Collins G
Hodges JS
Pettinelli C
Stein DS
Markowitz N
Reves R
Loveless MO
Crane L
Thompson M
1 October 1996